520 related articles for article (PubMed ID: 35763107)
1. Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression.
Liu R; Jia Y; Kong G; He A
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2215-2230. PubMed ID: 35763107
[TBL] [Abstract][Full Text] [Related]
2. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
3. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
4. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-145 Modulates
Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
[No Abstract] [Full Text] [Related]
6. The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m
Sun CY; Cao D; Du BB; Chen CW; Liu D
Int J Biol Sci; 2022; 18(7):2744-2758. PubMed ID: 35541906
[TBL] [Abstract][Full Text] [Related]
7. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts.
Imam H; Kim GW; Mir SA; Khan M; Siddiqui A
PLoS Pathog; 2020 Feb; 16(2):e1008338. PubMed ID: 32059034
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
Sugiokto FG; Saiada F; Zhang K; Li R
mBio; 2024 Feb; 15(2):e0316823. PubMed ID: 38236021
[TBL] [Abstract][Full Text] [Related]
9. The detection and functions of RNA modification m
Zhang W; Qian Y; Jia G
J Biol Chem; 2021 Aug; 297(2):100973. PubMed ID: 34280435
[TBL] [Abstract][Full Text] [Related]
10. Targeted m
Rauch S; He C; Dickinson BC
J Am Chem Soc; 2018 Sep; 140(38):11974-11981. PubMed ID: 30183280
[TBL] [Abstract][Full Text] [Related]
11. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
[TBL] [Abstract][Full Text] [Related]
12. Roles of RNA methylation by means of N
Wang S; Sun C; Li J; Zhang E; Ma Z; Xu W; Li H; Qiu M; Xu Y; Xia W; Xu L; Yin R
Cancer Lett; 2017 Nov; 408():112-120. PubMed ID: 28867248
[TBL] [Abstract][Full Text] [Related]
13. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
Imam H; Kim GW; Siddiqui A
Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
[TBL] [Abstract][Full Text] [Related]
14. Function and evolution of RNA N6-methyladenosine modification.
Zhu ZM; Huo FC; Pei DS
Int J Biol Sci; 2020; 16(11):1929-1940. PubMed ID: 32398960
[TBL] [Abstract][Full Text] [Related]
15. Functions of RNA N6-methyladenosine modification in cancer progression.
Chen B; Li Y; Song R; Xue C; Xu F
Mol Biol Rep; 2019 Feb; 46(1):1383-1391. PubMed ID: 30788764
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Hou G; Zhao X; Li L; Yang Q; Liu X; Huang C; Lu R; Chen R; Wang Y; Jiang B; Yu J
Nucleic Acids Res; 2021 Mar; 49(5):2859-2877. PubMed ID: 33577677
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine-dependent regulation of messenger RNA stability.
Wang X; Lu Z; Gomez A; Hon GC; Yue Y; Han D; Fu Y; Parisien M; Dai Q; Jia G; Ren B; Pan T; He C
Nature; 2014 Jan; 505(7481):117-20. PubMed ID: 24284625
[TBL] [Abstract][Full Text] [Related]
18. YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators.
Fei Q; Zou Z; Roundtree IA; Sun HL; He C
PLoS Biol; 2020 Apr; 18(4):e3000664. PubMed ID: 32267835
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21
Liu R; Miao J; Jia Y; Kong G; Hong F; Li F; Zhai M; Zhang R; Liu J; Xu X; Wang T; Liu H; Hu J; Yang Y; He A
Oncogene; 2023 May; 42(20):1607-1619. PubMed ID: 37012388
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine links RNA metabolism to cancer progression.
Dai D; Wang H; Zhu L; Jin H; Wang X
Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
